Page last updated: 2024-08-18

1-naphthylamine and Parkinson Disease

1-naphthylamine has been researched along with Parkinson Disease in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Iacono, RP; Toyama, SC	1
Olanow, CW	1
Hayes, HD	1
Dike, GL	1
Hauser, RA; Zesiewicz, TA	1
Hobson, P; Meara, J	1

Trials

1 trial(s) available for 1-naphthylamine and Parkinson Disease

Article	Year
Sertraline for the treatment of depression in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:5 Topics: 1-Naphthylamine; Aged; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Depression; Drug Interactions; Drug Therapy, Combination; Humans; Parkinson Disease; Pilot Projects; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Severity of Illness Index; Treatment Outcome	1997

Article

Year

Sertraline for the treatment of depression in Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:5

Topics: 1-Naphthylamine; Aged; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Depression; Drug Interactions; Drug Therapy, Combination; Humans; Parkinson Disease; Pilot Projects; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Severity of Illness Index; Treatment Outcome

1997

Other Studies

5 other study(ies) available for 1-naphthylamine and Parkinson Disease

Article	Year
Is it safe to combine a selective serotonin reuptake inhibitor with selegiline? The Annals of pharmacotherapy, 1994, Volume: 28, Issue:3 Topics: 1-Naphthylamine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Parkinson Disease; Paroxetine; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline	1994
A 61-year-old man with Parkinson's disease. JAMA, 1996, Mar-06, Volume: 275, Issue:9 Topics: 1-Naphthylamine; Antiparkinson Agents; Carbidopa; Depression; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Family Practice; Humans; Levodopa; Male; Middle Aged; Neurology; Neuroprotective Agents; Parkinson Disease; Selegiline; Sertraline; Vitamin E	1996
A 61-year-old man with Parkinson's disease. JAMA, 1996, Jul-10, Volume: 276, Issue:2 Topics: 1-Naphthylamine; Antidepressive Agents; Antiparkinson Agents; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline	1996
Triphasic waves in serotonin syndrome. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 62, Issue:2 Topics: 1-Naphthylamine; Aged; Amantadine; Antiparkinson Agents; Brain Diseases; Carbidopa; Drug Combinations; Drug Therapy, Combination; Electroencephalography; Hallucinations; Humans; Levodopa; Male; Myoclonus; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Sertraline; Syndrome	1997
Sertraline for the treatment of depression in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 1998, Volume: 13, Issue:3 Topics: 1-Naphthylamine; Aged; Antidepressive Agents; Depressive Disorder; Humans; Parkinson Disease; Personality Assessment; Sertraline; Treatment Outcome	1998